10-23104221-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000376510.8(MSRB2):āc.196A>Gā(p.Thr66Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0013 in 1,613,704 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00096 ( 0 hom., cov: 32)
Exomes š: 0.0013 ( 1 hom. )
Consequence
MSRB2
ENST00000376510.8 missense
ENST00000376510.8 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 5.32
Genes affected
MSRB2 (HGNC:17061): (methionine sulfoxide reductase B2) Predicted to enable actin binding activity; peptide-methionine (R)-S-oxide reductase activity; and zinc ion binding activity. Predicted to be involved in actin filament polymerization and protein repair. Predicted to be located in mitochondrion. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07840693).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSRB2 | NM_012228.4 | c.196A>G | p.Thr66Ala | missense_variant | 2/5 | ENST00000376510.8 | NP_036360.3 | |
MSRB2 | XM_011519426.3 | c.196A>G | p.Thr66Ala | missense_variant | 2/4 | XP_011517728.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSRB2 | ENST00000376510.8 | c.196A>G | p.Thr66Ala | missense_variant | 2/5 | 1 | NM_012228.4 | ENSP00000365693 | P1 | |
ENST00000655462.1 | n.116+29468T>C | intron_variant, non_coding_transcript_variant | ||||||||
MSRB2 | ENST00000472663.1 | c.79A>G | p.Thr27Ala | missense_variant, NMD_transcript_variant | 1/5 | 5 | ENSP00000434990 |
Frequencies
GnomAD3 genomes AF: 0.000959 AC: 146AN: 152234Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
146
AN:
152234
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000984 AC: 244AN: 247968Hom.: 1 AF XY: 0.000973 AC XY: 131AN XY: 134598
GnomAD3 exomes
AF:
AC:
244
AN:
247968
Hom.:
AF XY:
AC XY:
131
AN XY:
134598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00134 AC: 1951AN: 1461352Hom.: 1 Cov.: 30 AF XY: 0.00123 AC XY: 897AN XY: 727002
GnomAD4 exome
AF:
AC:
1951
AN:
1461352
Hom.:
Cov.:
30
AF XY:
AC XY:
897
AN XY:
727002
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000958 AC: 146AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000832 AC XY: 62AN XY: 74514
GnomAD4 genome
AF:
AC:
146
AN:
152352
Hom.:
Cov.:
32
AF XY:
AC XY:
62
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
15
ExAC
AF:
AC:
113
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.196A>G (p.T66A) alteration is located in exon 2 (coding exon 2) of the MSRB2 gene. This alteration results from a A to G substitution at nucleotide position 196, causing the threonine (T) at amino acid position 66 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at